MovDisordV3, Main, Exploration, bibRecord, 003837

Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP‐treated drug‐naïve primates

Identifieur interne : 003837 ( Main/Exploration ); précédent : 003836; suivant : 003838

Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP‐treated drug‐naïve primates

Auteurs : Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Ghassan Al-Barghouthy [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Mikko Kuoppamaki [Royaume-Uni, Finlande] ; C. Warren Olanow [États-Unis] ; Peter Jenner [Royaume-Uni]

Source :

Movement Disorders [ 0885-3185 ] ; 2005-03.

RBID : ISTEX:1C6BDCE76FD54515A084003412A7B77B261A62E2

English descriptors

KwdEn :
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (adverse effects), Animals, Antiparkinson Agents (administration & dosage), Antiparkinson Agents (therapeutic use), Callithrix, Carbidopa (administration & dosage), Carbidopa (therapeutic use), Catechols (administration & dosage), Catechols (therapeutic use), Dopamine Agents (adverse effects), Drug Administration Schedule, Drug Therapy, Combination, Dyskinesia, Drug-Induced (diagnosis), Dyskinesia, Drug-Induced (etiology), Dyskinesia, Drug-Induced (prevention & control), Female, Injections, Subcutaneous, Levodopa (administration & dosage), Levodopa (therapeutic use), Locomotion (drug effects), MPTP, MPTP Poisoning (chemically induced), MPTP Poisoning (prevention & control), Male, Nitriles, Severity of Illness Index, Substantia Nigra (drug effects), Time Factors, continuous dopaminergic stimulation, dyskinesia, entacapone, levodopa, primates.
MESH :
- chemical , administration & dosage : Antiparkinson Agents, Carbidopa, Catechols, Levodopa.
- chemical , adverse effects : 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Dopamine Agents.
- chemical , therapeutic use : Antiparkinson Agents, Carbidopa, Catechols, Levodopa.
- chemically induced : MPTP Poisoning.
- diagnosis : Dyskinesia, Drug-Induced.
- drug effects : Locomotion, Substantia Nigra.
- etiology : Dyskinesia, Drug-Induced.
- prevention & control : Dyskinesia, Drug-Induced, MPTP Poisoning.
- Animals, Callithrix, Drug Administration Schedule, Drug Therapy, Combination, Female, Injections, Subcutaneous, Male, Nitriles, Severity of Illness Index, Time Factors.

Abstract

The original article to which this Erratum refers has been published in Movement Disorders 2005;20(3)306–314.

Url:

DOI: 10.1002/mds.20421

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP‐treated drug‐naïve primates</title>
<author><name sortKey="Smith, Lance A" sort="Smith, Lance A" uniqKey="Smith L" first="Lance A." last="Smith">Lance A. Smith</name>
</author>
<author><name sortKey="Jackson, Michael J" sort="Jackson, Michael J" uniqKey="Jackson M" first="Michael J." last="Jackson">Michael J. Jackson</name>
</author>
<author><name sortKey="Al Arghouthy, Ghassan" sort="Al Arghouthy, Ghassan" uniqKey="Al Arghouthy G" first="Ghassan" last="Al-Barghouthy">Ghassan Al-Barghouthy</name>
</author>
<author><name sortKey="Rose, Sarah" sort="Rose, Sarah" uniqKey="Rose S" first="Sarah" last="Rose">Sarah Rose</name>
</author>
<author><name sortKey="Kuoppamaki, Mikko" sort="Kuoppamaki, Mikko" uniqKey="Kuoppamaki M" first="Mikko" last="Kuoppamaki">Mikko Kuoppamaki</name>
</author>
<author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C. Warren" last="Olanow">C. Warren Olanow</name>
</author>
<author><name sortKey="Jenner, Peter" sort="Jenner, Peter" uniqKey="Jenner P" first="Peter" last="Jenner">Peter Jenner</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:1C6BDCE76FD54515A084003412A7B77B261A62E2</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1002/mds.20421</idno>
<idno type="url">https://api.istex.fr/document/1C6BDCE76FD54515A084003412A7B77B261A62E2/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">004334</idno>
<idno type="wicri:Area/Istex/Curation">004334</idno>
<idno type="wicri:Area/Istex/Checkpoint">002245</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Smith L:multiple:small:doses</idno>
<idno type="wicri:Area/Main/Merge">004F22</idno>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:BD388FE8C220A542359930412AA51EAEE3F12AEF</idno>
<idno type="url">https://api.istex.fr/document/BD388FE8C220A542359930412AA51EAEE3F12AEF/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000662</idno>
<idno type="wicri:Area/Istex/Curation">000662</idno>
<idno type="wicri:Area/Istex/Checkpoint">002244</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Smith L:multiple:small:doses</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15490461</idno>
<idno type="wicri:Area/PubMed/Corpus">003214</idno>
<idno type="wicri:Area/PubMed/Curation">003214</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003052</idno>
<idno type="wicri:Area/Ncbi/Merge">001074</idno>
<idno type="wicri:Area/Ncbi/Curation">001074</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001074</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Smith L:multiple:small:doses</idno>
<idno type="wicri:Area/Main/Merge">004F21</idno>
<idno type="wicri:Area/Main/Curation">003837</idno>
<idno type="wicri:Area/Main/Exploration">003837</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP‐treated drug‐naïve primates</title>
<author><name sortKey="Smith, Lance A" sort="Smith, Lance A" uniqKey="Smith L" first="Lance A." last="Smith">Lance A. Smith</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Neurodegenerative Diseases Research Centre, GKT School of Biomedical Sciences, King's College, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jackson, Michael J" sort="Jackson, Michael J" uniqKey="Jackson M" first="Michael J." last="Jackson">Michael J. Jackson</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Neurodegenerative Diseases Research Centre, GKT School of Biomedical Sciences, King's College, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Al Arghouthy, Ghassan" sort="Al Arghouthy, Ghassan" uniqKey="Al Arghouthy G" first="Ghassan" last="Al-Barghouthy">Ghassan Al-Barghouthy</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Neurodegenerative Diseases Research Centre, GKT School of Biomedical Sciences, King's College, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rose, Sarah" sort="Rose, Sarah" uniqKey="Rose S" first="Sarah" last="Rose">Sarah Rose</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Neurodegenerative Diseases Research Centre, GKT School of Biomedical Sciences, King's College, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kuoppamaki, Mikko" sort="Kuoppamaki, Mikko" uniqKey="Kuoppamaki M" first="Mikko" last="Kuoppamaki">Mikko Kuoppamaki</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Neurodegenerative Diseases Research Centre, GKT School of Biomedical Sciences, King's College, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Finlande</country>
<wicri:regionArea>Satakunta Central Hospital and Satakunnan Neurologipalvelu Oy, Pori</wicri:regionArea>
<wicri:noRegion>Pori</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C. Warren" last="Olanow">C. Warren Olanow</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Mount Sinai School of Medicine, New York, New York</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jenner, Peter" sort="Jenner, Peter" uniqKey="Jenner P" first="Peter" last="Jenner">Peter Jenner</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Neurodegenerative Diseases Research Centre, GKT School of Biomedical Sciences, King's College, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2005-03">2005-03</date>
<biblScope unit="vol">20</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="388">388</biblScope>
<biblScope unit="page" to="388">388</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">1C6BDCE76FD54515A084003412A7B77B261A62E2</idno>
<idno type="DOI">10.1002/mds.20421</idno>
<idno type="ArticleID">MDS20421</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (adverse effects)</term>
<term>Animals</term>
<term>Antiparkinson Agents (administration & dosage)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Callithrix</term>
<term>Carbidopa (administration & dosage)</term>
<term>Carbidopa (therapeutic use)</term>
<term>Catechols (administration & dosage)</term>
<term>Catechols (therapeutic use)</term>
<term>Dopamine Agents (adverse effects)</term>
<term>Drug Administration Schedule</term>
<term>Drug Therapy, Combination</term>
<term>Dyskinesia, Drug-Induced (diagnosis)</term>
<term>Dyskinesia, Drug-Induced (etiology)</term>
<term>Dyskinesia, Drug-Induced (prevention & control)</term>
<term>Female</term>
<term>Injections, Subcutaneous</term>
<term>Levodopa (administration & dosage)</term>
<term>Levodopa (therapeutic use)</term>
<term>Locomotion (drug effects)</term>
<term>MPTP</term>
<term>MPTP Poisoning (chemically induced)</term>
<term>MPTP Poisoning (prevention & control)</term>
<term>Male</term>
<term>Nitriles</term>
<term>Severity of Illness Index</term>
<term>Substantia Nigra (drug effects)</term>
<term>Time Factors</term>
<term>continuous dopaminergic stimulation</term>
<term>dyskinesia</term>
<term>entacapone</term>
<term>levodopa</term>
<term>primates</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Carbidopa</term>
<term>Catechols</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine</term>
<term>Dopamine Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Carbidopa</term>
<term>Catechols</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>MPTP Poisoning</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Locomotion</term>
<term>Substantia Nigra</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
<term>MPTP Poisoning</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Callithrix</term>
<term>Drug Administration Schedule</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Injections, Subcutaneous</term>
<term>Male</term>
<term>Nitriles</term>
<term>Severity of Illness Index</term>
<term>Time Factors</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The original article to which this Erratum refers has been published in Movement Disorders 2005;20(3)306–314.</div>
</front>
</TEI>
<affiliations><list><country><li>Finlande</li>
<li>Royaume-Uni</li>
<li>États-Unis</li>
</country>
<region><li>Angleterre</li>
<li>Grand Londres</li>
<li>État de New York</li>
</region>
<settlement><li>Londres</li>
</settlement>
</list>
<tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Smith, Lance A" sort="Smith, Lance A" uniqKey="Smith L" first="Lance A." last="Smith">Lance A. Smith</name>
</region>
<name sortKey="Al Arghouthy, Ghassan" sort="Al Arghouthy, Ghassan" uniqKey="Al Arghouthy G" first="Ghassan" last="Al-Barghouthy">Ghassan Al-Barghouthy</name>
<name sortKey="Jackson, Michael J" sort="Jackson, Michael J" uniqKey="Jackson M" first="Michael J." last="Jackson">Michael J. Jackson</name>
<name sortKey="Jenner, Peter" sort="Jenner, Peter" uniqKey="Jenner P" first="Peter" last="Jenner">Peter Jenner</name>
<name sortKey="Kuoppamaki, Mikko" sort="Kuoppamaki, Mikko" uniqKey="Kuoppamaki M" first="Mikko" last="Kuoppamaki">Mikko Kuoppamaki</name>
<name sortKey="Rose, Sarah" sort="Rose, Sarah" uniqKey="Rose S" first="Sarah" last="Rose">Sarah Rose</name>
</country>
<country name="Finlande"><noRegion><name sortKey="Kuoppamaki, Mikko" sort="Kuoppamaki, Mikko" uniqKey="Kuoppamaki M" first="Mikko" last="Kuoppamaki">Mikko Kuoppamaki</name>
</noRegion>
</country>
<country name="États-Unis"><region name="État de New York"><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C. Warren" last="Olanow">C. Warren Olanow</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003837 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003837 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:1C6BDCE76FD54515A084003412A7B77B261A62E2
   |texte=   Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP‐treated drug‐naïve primates
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP‐treated drug‐naïve primates

Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP‐treated drug‐naïve primates

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.